News

While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s ...
Kindeva joins forces with Rocket Science Health to pioneer new intranasal delivery platform: Woodbury, Minnesota Friday, June 20, 2025, 17:00 Hrs [IST] Kindeva, a global CDMO and ...
As peak travel season approaches, Brits may find that a familiar in-flight nuisance is on the rise - but there is one thing ...
Dihydroergotamine (DHE) is an older drug used for migraine relief. Learn about new formulations and find out if you're a good candidate for this powerful treatment.
Tonix Pharmaceuticals (NASDAQ: TNXP) a fully-integrated biotechnology company with marketed products and late-stage development candidates, announced ...
It was another big week for AI-related funding, topped off by Scale AI’s massive new investment from Meta. We also saw big ...
Discover the top reasons why your nose runs when you cry, and how to relieve sinus pressure after a good cry session, ...
Iconovo AB (publ), a leader in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, today announce that the development of spray-dried formulations of intranas ...
We recently wrote an introductory overview of navigating the Common Law Research Exemption and the Hatch-Waxman Safe Harbor and an exploration of the application of the Common Law Research Exemption.
A nasal spray that combats COVID-19 infection could be in British pharmacies by the summer, according to the treatment's lead researcher. The spray, which is being developed by scientists at the ...
Learn why vaccination will be the most effective way for turkey producers to control the respiratory disease in the U.S.